Pathological precision diagnosis and recent advances in HER2 low and ultralow in breast cancer: a narrative review
{{output}}
Background and objective: The novel antibody-drug conjugate (ADC) analogues are emerging in the field of human epidermal growth factor receptor 2 (HER2) low and ultralow breast cancer, and accurate screening of patients with HER2... ...
